Ravichandran Veerasamy
Ravichandran Veerasamy publishes mostly in Organic Chemistry, Molecular Biology and Computational Theory and Mathematics, on topics such as Synthesis and biological activity, Computational Drug Discovery Methods and Histone Deacetylase Inhibitors Research.
- World rank
- #1,681,475 of 7,710,434 ranked researchers
- Rank in Malaysia
- #6,404 of 41,196
- Works
- 142
- Citations
- 4.2k
- Citations per work
- 29.2
What does Ravichandran Veerasamy research?
Ravichandran Veerasamy's work is mostly in Chemistry (22%), Biochemistry, Genetics and Molecular Biology (21%), Medicine (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5639.1%
- Physical Sciences4028.0%
- Chemistry3121.6%
- Computer Science96.4%
- Life Sciences2920.6%
- Health Sciences1712.3%
- Medicine1712.3%
- 1Organic Chemistry22% of their works
- 2Molecular Biology21% of their works
- 3Computational Theory and Mathematics6% of their works
- 4Infectious Diseases5% of their works
- 5Oncology4% of their works
- 6Pharmacology4% of their works
Research topics
- Synthesis and biological activity
- Computational Drug Discovery Methods
- Histone Deacetylase Inhibitors Research
- Click Chemistry and Applications
- Protein Degradation and Inhibitors
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Characterization of Heterocyclic Compounds
- Cholinesterase and Neurodegenerative Diseases
Which keywords describe Ravichandran Veerasamy's research?
The keywords of their largest research topics: Medicinal Chemistry, Molecular Docking, Anticancer Agents, Heterocyclic Compounds, Drug Target Identification, Virtual Screening, Drug Discovery and HDAC Inhibitors.
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Biological Activities
- BET Bromodomains
- Click Chemistry
- Antimicrobial
- HDAC Inhibitors
- Virtual Screening
- Heterocyclic Compounds
- Molecular Docking
- Medicinal Chemistry
- Anticancer Agents
- Drug Target Identification
- Drug Discovery
- Histone Deacetylases
- Synthesis
- Copper-Catalyzed Cycloaddition
- PROTACs
- Phenothiazines
- Biological Evaluation
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Medicinal Chemistry572 topics
- Molecular Docking342 topics
- Anticancer Agents321 topic
- Heterocyclic Compounds321 topic
- Drug Target Identification251 topic
- Virtual Screening251 topic
- Drug Discovery242 topics
- HDAC Inhibitors201 topic
- Histone Deacetylases201 topic
- Antimicrobial192 topics
- Synthesis192 topics
- Click Chemistry151 topic
- Copper-Catalyzed Cycloaddition151 topic
- BET Bromodomains121 topic
- PROTACs121 topic
- Biological Activities101 topic
- Phenothiazines101 topic
- Acetylcholinesterase91 topic
- Biological Evaluation91 topic
- Cholinesterase Inhibitors91 topic
- Triazines91 topic
Where does Ravichandran Veerasamy work?
Ravichandran Veerasamy's main affiliation in the publication record is AIMST University, Malaysia.
How many publications and citations does Ravichandran Veerasamy have?
OpenAlex counts 142 works and 4,152 citations for Ravichandran Veerasamy, an h-index of 28, ranking #1,681,475 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ravichandran Veerasamy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.